How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MY

NASDAQ:MYMD
Get a brief AI stock analysisSaves ~ 15 minutes of your time

MY

MyMD Pharmaceuticals IncNASDAQ MYMD Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is MYMD undervalued compared to its fair value?

The fair value of MYMD stock is hidden USD. Relative to the market price of 1.795 USD MyMD Pharmaceuticals Inc is hidden.

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. ...[More about valuation]

MyMD Pharmaceuticals Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.004 $B

Price:

1.795 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

0.064

FINANCIALS

MyMD Pharmaceuticals financial for reporting period

Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0038 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
0.0029 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

Balance Sheet

0.022 B
0.016 B

Financial Position Analysis

Assets

0.022 B
Current Assets
0.0097 B
Total non-current assets
0.012 B

Total current liabilities
0.0057 B
Total non-current liabilities
0 B

Cash Flow Statement

-0.0032 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0032 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

MyMD Pharmaceuticals fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is MYMD attractive for investment based on fundamental analysis?

MYMD stock rating is hidden. MyMD Pharmaceuticals is a hidden by Eyestock methodology.

Get MYMD Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

Debt / Equity ratio:

ROE:

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

MYMD analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for MYMD to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

MyMD Pharmaceuticals Inc competitors

LL

LLY

Eli Lilly and Co

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs ...

Discover

NO

NOVO B.CO

Novo Nordisk A/S

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged i...

Discover

JN

JNJ

Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. The company is headquartered in Ne...

Discover

MyMD Pharmaceuticals Inc dividends

MYMD dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About MYMD stock

About the company MyMD Pharmaceuticals Inc

Market cap $B

0.004

Dividend yield

Shares outstanding

39.47 B

MyMD Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company, which engages in the development of drug products targeting aging, age-related, and autoimmune diseases, chronic pain, anxiety, and sleep disorders. The company is headquartered in Baltimore, Maryland and currently employs 9 full-time employees. The company went IPO on 2008-07-24. The firm is focused on developing and commercializing two therapeutic platforms based on therapeutic targets, MYMD-1 and Supera-CBD. MYMD-1 is a clinical-stage small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. MYMD-1 is being developed to treat age-related illnesses, such as frailty and sarcopenia. MYMD-1 works by regulating the release of numerous pro-inflammatory cytokines, such as TNF-a, interleukin 6 (IL-6) and interleukin 17 (IL-17). Supera-CBD is a synthetic analog of cannabidiol (CBD) being developed to treat various conditions, including epilepsy, pain and anxiety/depression, through its effects on the CB2 receptor, opioid receptors and monoamine oxidase enzyme (MAO) type B. Supera-CBD is also used in treating neuroinflammatory and neurodegenerative diseases.

MYMD profile

  • Ticker

    MYMD

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    24 July 2008

  • Sector

    Healthсare

  • Industry

    Pharmaceuticals

  • Employees

    9

  • City

    Baltimore

  • Address

    855 N. Wolfe Street, Suite 623

  • Cusip

    62856X102